Effect of Stress-Related Neural Pathways&#xa0;on the Cardiovascular Benefit&#xa0;of Physical Activity

Atrial Fibrillation

Association of comorbidity patterns with outcomes and relation with the ABC pathway effectiveness in European patients with Atrial Fibrillation

Heart Rhythm

Romiti GF, Corica B, Mei DA, Vitolo M, Bucci T, Bisson A, Fauchier L, Boriani G, Proietti M, Lip GYH

doi: 10.1016/j.hrthm.2025.02.049

Heart Failure

Effect of Finerenone on the KCCQ in Patients With HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HF

J Am Coll Cardiol

Yang M, Henderson AD, Talebi A, Atherton JJ, Chiang CE, Chopra V, Comin-Colet J, Kosiborod MN, Kerr Saraiva JF, Claggett BL, Desai AS, Kolkhof P, Viswanathan P, Lage A, Lam CSP, Senni M, Shah SJ, Rohwedder K, Voors AA, Zannad F, Pitt B, Vaduganathan M, Jhund PS, Solomon SD, McMurray JJV

doi: 10.1016/j.jacc.2024.09.023

Cardiovascular Risk and DiseasesHeart Failure

Prenatal Exposure to Severe Stress and the Risk of Heart Failure Up to Middle-Age

JACC Heart Fail

Yang F, Janszky I, Roos N, Li J, László KD

doi: 10.1016/j.jchf.2024.01.009

Heart, Artery and Coronary Diseases

Using heart rate data from wrist worn activity trackers to define thresholds for moderate to vigorous physical activity in children and young people with cystic fibrosis

J Cyst Fibros

Tanriver G, Stanojevic S, Filipow N, Douglas H, Raywood E, Kapoor K, Davies G, Murray N, O'Connor R, Robinson E, Main E

doi: 10.1016/j.jcf.2024.10.014

Heart, Artery and Coronary DiseasesTherapy and Intervention

Effect of Valve Type and Anesthesia Strategy for TAVR: 5-Year Results of the SOLVE-TAVI Trial

J Am Coll Cardiol

Feistritzer HJ, Kurz T, Vonthein R, Schröder L, Stachel G, Eitel I, Marquetand C, Saraei R, Kirchhof E, Heringlake M, Abdel-Wahab M, Desch S, Thiele H, SOLVE-TAVI Investigators

doi: 10.1016/j.jacc.2024.09.007

Atrial FibrillationThrombosis and StrokeTherapy and Intervention

Effect of Screening for Undiagnosed Atrial Fibrillation on Stroke Prevention

J Am Coll Cardiol

Lopes RD, Atlas SJ, Go AS, Lubitz SA, McManus DD, Dolor RJ, Chatterjee R, Rothberg MB, Rushlow DR, Crosson LA, Aronson RS, Patlakh M, Gallup D, Mills DJ, O'Brien EC, Singer DE

doi: 10.1016/j.jacc.2024.08.019

Heart Failure

Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Trials

J Am Coll Cardiol

Verma S, Butler J, Borlaug BA, Davies M, Kitzman DW, Shah SJ, Petrie MC, Barros E, Rönnbäck C, Vestergaard LS, Schou M, Ezekowitz JA, Sharma K, Patel S, Chinnakondepalli KM, Kosiborod MN, STEP-HFpEF Trial Committees and Investigators

doi: 10.1016/j.jacc.2024.06.001

Heart Failure

Vericiguat and Cardiovascular Outcomes in Heart Failure by Baseline Diabetes Status: Insights From the VICTORIA Trial

JACC Heart Fail

Khan MS, Butler J, Young R, Lewis BS, Escobedo J, Refsgaard J, Reyes E, Roessig L, Blaustein RO, Lam CSP, Voors AA, Ponikowski P, Anstrom KJ, Armstrong PW, VICTORIA Study Group

doi: 10.1016/j.jchf.2024.05.007

Further Publications

Family Screening in Hypertrophic Cardiomyopathy: Identification of Relatives With Low Yield From Systematic Follow-Up

J Am Coll Cardiol

Silajdzija E, Rasmus Vissing C, Basse Christensen E, Lamiokor Mills H, Olivia Kock T, Andersen LJ, Snoer M, Thune JJ, Daniel Bartels E, Axelsson Raja A, Hørby Christensen A, Bundgaard H

doi: 10.1016/j.jacc.2024.08.011

Related content

Association of comorbidity patterns with outcomes and relation with the ABC pathway effectiveness in European patients with Atrial Fibrillation

Effect of Finerenone on the KCCQ in Patients With HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HF

Prenatal Exposure to Severe Stress and the Risk of Heart Failure Up to Middle-Age

Using heart rate data from wrist worn activity trackers to define thresholds for moderate to vigorous physical activity in children and young people with cystic fibrosis

Effect of Valve Type and Anesthesia Strategy for TAVR: 5-Year Results of the SOLVE-TAVI Trial

Effect of Screening for Undiagnosed Atrial Fibrillation on Stroke Prevention

Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Trials

Vericiguat and Cardiovascular Outcomes in Heart Failure by Baseline Diabetes Status: Insights From the VICTORIA Trial

Family Screening in Hypertrophic Cardiomyopathy: Identification of Relatives With Low Yield From Systematic Follow-Up